We are live on ! Find out more

974 hedge funds and large institutions have $21.1B invested in Labcorp in 2025 Q2 according to their latest regulatory filings, with 104 funds opening new positions, 342 increasing their positions, 363 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $79.4M | Put options by funds: $60.2M

16% more capital invested

Capital invested by funds: $18.2B → $21.1B (+$2.9B)

12% more first-time investments, than exits

New positions opened: 104 | Existing positions closed: 93

8% more funds holding in top 10

Funds holding in top 10: 1314 (+1)

2.61% more ownership

Funds ownership: 93.53%96.14% (+2.6%)

0% less funds holding

Funds holding: 976974 (-2)

6% less repeat investments, than reductions

Existing positions increased: 342 | Existing positions reduced: 363

Holders
974
Holders Change
-2
Holders Change %
-0.2%
% of All Funds
12.79%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.18%
New
104
Increased
342
Reduced
363
Closed
93
Calls
$79.4M
Puts
$60.2M
Net Calls
+$19.2M
Net Calls Change
+$23.7M

LH Hedge Fund Activity: Q2 2025 in Review

974 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2025, worth a combined $21.1B — up 16% from $18.2B a quarter earlier.

Buyers outnumbered sellers: 104 funds opened new LH positions and 93 closed out — a net gain of 11 holders — while 342 added to existing stakes and 363 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $521M. The largest seller was Amundi, cutting an estimated $195M.

  • 974 institutional investors held Labcorp (LH) as of Q2 2025, down from 976 in Q1 2025.
  • Funds reported $21.1B of Labcorp stock for Q2 2025, up 16% quarter-over-quarter.
  • 104 funds opened new Labcorp positions in Q2 2025 and 93 closed out, a net change of +11 holders.
  • The largest Labcorp buyer in Q2 2025 was Victory Capital Management, an estimated $521M added.
  • The largest Labcorp seller in Q2 2025 was Amundi, an estimated $195M sold.

Based on aggregated 13F filings for Q2 2025.